|
|
|
|
|
by spott
592 days ago
|
|
To me, the Alzheimer’s drug story is an argument for right to try laws. If the drug is available to the desperate, then the push by the public to shortcut the process goes away and the process can be done correctly. Those who are desperate can try, with the understanding that it might not work. The process can continue unmodified because there isn’t a pressure to get the drug out to the public because it is available. |
|
If you allow that, you're back to HCQ for Covid territory. Or all the autism "treatments".
The problem is that most people think of medical outcomes as having 2 results when there are 4.
The 2 everybody thinks about are "drug given->patient gets better" and "drug not given->patient gets worse". But there are two more cases.
"drug not given->patient gets better" is wonderful in the super-rare cases when it happens and is totally unproblematic.
The problem is that the case "drug given->patient gets worse" is common--doubly so for experimental treatments--exponentially so for experimental cancer treatments. And the problem is that it can be due to either the disease or the drug or both. This case is the one that you can't explain in a soundbite. And it's one of the big hurdles in drug discovery.
The vast majority of people simply will never get this. We know this. We watched it play out in real time--multiple times.
Sure, if you made everybody pass a Bayesian statistics exam before they could get their treatment, that would work. But then you'd be "gatekeeping a cure".
Stupidity is the norm, not the exception, and greedy, evil bastards are not unrare. Your rules have to, sadly, take that into account.